144 related articles for article (PubMed ID: 32463234)
1. Impact of C28 Oligosaccharide on Adjuvant Activity of QS-7 Analogues.
Škalamera Đ; Kim H; Zhang P; Michalek SM; Wang P
J Org Chem; 2020 Dec; 85(24):15837-15848. PubMed ID: 32463234
[TBL] [Abstract][Full Text] [Related]
2. Development of Improved Vaccine Adjuvants Based on the Saponin Natural Product QS-21 through Chemical Synthesis.
Fernández-Tejada A; Tan DS; Gin DY
Acc Chem Res; 2016 Sep; 49(9):1741-56. PubMed ID: 27568877
[TBL] [Abstract][Full Text] [Related]
3. QS-21 and QS-7: purified saponin adjuvants.
Kensil CR; Wu JY; Anderson CA; Wheeler DA; Amsden J
Dev Biol Stand; 1998; 92():41-7. PubMed ID: 9554258
[TBL] [Abstract][Full Text] [Related]
4. Structural Effect on Adjuvanticity of Saponins.
Wang P; Ding X; Kim H; Michalek SM; Zhang P
J Med Chem; 2020 Mar; 63(6):3290-3297. PubMed ID: 32101001
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Evaluation of QS-7-Based Vaccine Adjuvants.
Wang P; Škalamera Đ; Sui X; Zhang P; Michalek SM
ACS Infect Dis; 2019 Jun; 5(6):974-981. PubMed ID: 30920199
[TBL] [Abstract][Full Text] [Related]
6. QS-21 Adjuvant: Laboratory-Scale Purification Method and Formulation Into Liposomes.
Brunner L; Barnier-Quer C; Collin N
Methods Mol Biol; 2017; 1494():73-86. PubMed ID: 27718186
[TBL] [Abstract][Full Text] [Related]
7. QS-21 structure/function studies: effect of acylation on adjuvant activity.
Liu G; Anderson C; Scaltreto H; Barbon J; Kensil CR
Vaccine; 2002 Jun; 20(21-22):2808-15. PubMed ID: 12034108
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Evaluation of a QS-17/18-Based Vaccine Adjuvant.
Wang P; Škalamera Đ; Sui X; Zhang P; Michalek SM
J Med Chem; 2019 Feb; 62(3):1669-1676. PubMed ID: 30656932
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure verification of the vaccine adjuvant QS-7-Api. Synthetic access to homogeneous Quillaja saponaria immunostimulants.
Deng K; Adams MM; Gin DY
J Am Chem Soc; 2008 May; 130(18):5860-1. PubMed ID: 18410100
[TBL] [Abstract][Full Text] [Related]
10. Structure Elucidation of Triterpenoid Saponins Found in an Immunoadjuvant Preparation of
Wallace F; Fontana C; Ferreira F; Olivaro C
Molecules; 2022 Apr; 27(8):. PubMed ID: 35458600
[TBL] [Abstract][Full Text] [Related]
11. Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex.
Kensil CR; Patel U; Lennick M; Marciani D
J Immunol; 1991 Jan; 146(2):431-7. PubMed ID: 1987271
[TBL] [Abstract][Full Text] [Related]
12. Effect of a novel saponin adjuvant derived from Quillaja saponaria on the immune response to recombinant hepatitis B surface antigen.
So HS; Yoon HS; Choi DY; Kwon YS; Sung JH; Lee TG; Park ES; Cho HS; Lee BM; Cho JM; Ryu WS
Mol Cells; 1997 Apr; 7(2):178-86. PubMed ID: 9163729
[TBL] [Abstract][Full Text] [Related]
13. Acylated and deacylated quillaja saponin-21 adjuvants have opposite roles when utilized for immunization of C57BL/6 mice model with MOG
Heidari AR; Boroumand-Noughabi S; Nosratabadi R; Lavi Arab F; Tabasi N; Rastin M; Mahmoudi M
Mult Scler Relat Disord; 2019 Apr; 29():68-82. PubMed ID: 30685444
[TBL] [Abstract][Full Text] [Related]
14. Saponin adjuvant enhancement of antigen-specific immune responses to an experimental HIV-1 vaccine.
Wu JY; Gardner BH; Murphy CI; Seals JR; Kensil CR; Recchia J; Beltz GA; Newman GW; Newman MJ
J Immunol; 1992 Mar; 148(5):1519-25. PubMed ID: 1538134
[TBL] [Abstract][Full Text] [Related]
15. Immunological adjuvant activities of saponin extracts from the pods of Acacia concinna.
Kukhetpitakwong R; Hahnvajanawong C; Homchampa P; Leelavatcharamas V; Satra J; Khunkitti W
Int Immunopharmacol; 2006 Nov; 6(11):1729-35. PubMed ID: 16979128
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant activities of saponins from the root of Polygala senega L.
Katselis GS; Estrada A; Gorecki DK; Barl B
Can J Physiol Pharmacol; 2007 Nov; 85(11):1184-94. PubMed ID: 18066120
[TBL] [Abstract][Full Text] [Related]
17. Development of semisynthetic triterpenoid saponin derivatives with immune stimulating activity.
Marciani DJ; Press JB; Reynolds RC; Pathak AK; Pathak V; Gundy LE; Farmer JT; Koratich MS; May RD
Vaccine; 2000 Jul; 18(27):3141-51. PubMed ID: 10856794
[TBL] [Abstract][Full Text] [Related]
18. Advances in saponin-based adjuvants.
Sun HX; Xie Y; Ye YP
Vaccine; 2009 Mar; 27(12):1787-96. PubMed ID: 19208455
[TBL] [Abstract][Full Text] [Related]
19. Formulation of the purified fusion protein of respiratory syncytial virus with the saponin QS-21 induces protective immune responses in Balb/c mice that are similar to those generated by experimental infection.
Hancock GE; Speelman DJ; Frenchick PJ; Mineo-Kuhn MM; Baggs RB; Hahn DJ
Vaccine; 1995 Mar; 13(4):391-400. PubMed ID: 7793137
[TBL] [Abstract][Full Text] [Related]
20. The predominant Quillaja Saponaria fraction, QS-18, is safe and effective when formulated in a liposomal murine cancer peptide vaccine.
Zhou S; Song Y; Nilam A; Luo Y; Huang WC; Long MD; Lovell JF
J Control Release; 2024 May; 369():687-695. PubMed ID: 38575073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
